Transgene S.a annual net income
2020
2021
2022
2023
2024
2025
Transgene S.a Net Income Growth & History (TNG)
Transgene S.a's net income was −€37.5M for fiscal 2025.
View full Transgene S.a company overviewTransgene S.a annual net income history
| Fiscal year | Period ended | Net income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −€37.5M | −€3.6M | — |
| 2024 | 2024-12-31 | −€34.0M | −€11.6M | — |
| 2023 | 2023-12-31 | −€22.3M | €10.5M | — |
| 2022 | 2022-12-31 | −€32.8M | −€13.3M | — |
| 2021 | 2021-12-31 | −€19.5M | −€2.3M | — |
| 2020 | 2020-12-31 | −€17.2M | — | — |
Transgene S.a net income trends
Over the last five fiscal years, Transgene S.a's net income decreased from −€17.2M to −€37.5M, a change of −€20.3M.
About the metric
What net income means
Net income is a company’s bottom-line profit or loss after operating costs, interest, taxes, and other reported income and expenses. It shows how much of a company’s revenue ultimately remained as earnings, or how large its loss was, during a fiscal period.
Calculation and source
reported net income
TickerStat standardizes consolidated net income or profit and loss reported in company official filings for aligned fiscal periods. It is not adjusted earnings, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Transgene S.a source filings ↗Community posts
Transgene reports €92.8 million in liquidity as vaccine development advances
Transgene ($TNG) reported €92.8 million in cash, cash equivalents and other current financial assets at its half-year end, compared with €111.9 million at the start of the year. First-half cash burn increased to €20.3 million from €18.8 mil ...
